TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer
暂无分享,去创建一个
Y. Yoneshima | E. Iwama | R. Ibusuki | I. Okamoto | Atsushi Shimauchi | Hirono Tsutsumi | Kentaro Tanaka
暂无分享,去创建一个
Y. Yoneshima | E. Iwama | R. Ibusuki | I. Okamoto | Atsushi Shimauchi | Hirono Tsutsumi | Kentaro Tanaka